Abstract
Our concern is with the evaluation of treatments for amblyopia, specifically with that of occlusion therapy. Some of the issues considered here are also relevant to the new pharmacological treatments under development (e.g. see Leguire, 1993).
© 1995 Optical Society of America
PDF ArticleMore Like This
C.O.T. Gretchen Van Boemel and Thomas E. Ogden
MD4 Noninvasive Assessment of the Visual System (NAVS) 1986
T. Rowan Candy, Anthony M. Norcia, and Uri Polat
SaA.1 Vision Science and its Applications (VSIA) 1998
Suzanne P. McKee, Clifton M. Schor, Scott B. Steinman, Nance Wilson, Gary G. Koch, Sonia K. Davis, Charlene Hsu-Winges, Susan H. Day, Christine L. Chan, J. Anthony Movshon, Merton C. Flom, Dennis M. Lev, and John T. Flynn
SuD2 Noninvasive Assessment of the Visual System (NAVS) 1992